Poignard P, Sabbe R, Picchio G R, Wang M, Gulizia R J, Katinger H, Parren P W, Mosier D E, Burton D R
Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA.
Immunity. 1999 Apr;10(4):431-8. doi: 10.1016/s1074-7613(00)80043-6.
Neutralizing antibodies can protect against challenge with HIV-1 in vivo if present at appropriate concentrations at the time of viral challenge, but any role in the control of established infection is unclear. Here, we show that high serum concentrations of neutralizing monoclonal antibodies, either singly or as a cocktail, have little sustained effect on viral load in established HIV-1 infection in hu-PBL-SCID mice. In some instances, virus replication of neutralization-sensitive virus continues even in the presence of high levels of neutralizing antibody. In most instances, neutralization escape occurs in a few days, even from a cocktail of three antibodies that recognize distinct epitopes. The results imply that humoral immunity is unlikely to play a significant role in the control of established HIV-1 infection in humans.
如果在病毒攻击时中和抗体以适当浓度存在,那么它们可以在体内保护机体免受HIV-1攻击,但它们在已建立感染的控制中所起的任何作用尚不清楚。在此,我们表明,在hu-PBL-SCID小鼠已建立的HIV-1感染中,高血清浓度的中和单克隆抗体,无论是单独使用还是作为混合物使用,对病毒载量几乎没有持续影响。在某些情况下,即使存在高水平的中和抗体,中和敏感病毒的病毒复制仍会继续。在大多数情况下,即使是来自识别不同表位的三种抗体的混合物,也会在几天内发生中和逃逸。这些结果表明,体液免疫不太可能在人类已建立的HIV-1感染控制中发挥重要作用。